← Back to Search

N/A

Dietary Changes for Psoriatic Arthritis (DIPSA Trial)

N/A
Waitlist Available
Led By Alexis Ogdie-Beatty, MD, MSCE
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Required Rheumatologist-confirmed diagnosis of PsA fulfilling Classification of Psoriatic Arthritis Criteria (CASPAR)
Age 18-80
Must not have
Use of systemic corticosteroids
All persons who would be placed at an increased risk including any medical condition that will impair the ability of the person to participate in a nutritional intervention study (e.g. insulin dependent diabetes, use of coumadin, advanced malignancy, inflammatory bowel disease, dementia)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up varying times: (at baseline) 0, 4, 8, 12, 16, 20, 24 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether a change in diet can help people with psoriatic arthritis.

Who is the study for?
This trial is for adults aged 18-80 with a BMI between 25 and 40, diagnosed with Psoriatic Arthritis by a rheumatologist. Participants must have been on stable PsA treatment for at least three months, own a smartphone or be willing to use one provided, and are open to changing their diet for the study duration. Exclusions include eating disorders, certain medical conditions like insulin-dependent diabetes or advanced cancer, food allergies related to the study diets, inability to consent or read/write in English.
What is being tested?
The trial is testing two different diets' effects on psoriatic arthritis over a period of 24 weeks. Patients will be assigned one of these diets and will need to adhere strictly while attending regular follow-up visits. The goal is to see if dietary changes can improve symptoms associated with PsA.
What are the potential side effects?
Since this trial involves dietary interventions rather than medication, side effects may include changes in weight or digestive discomfort as participants adjust to new eating habits. Specific side effects will depend on individual health conditions and the nature of diet changes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My Psoriatic Arthritis diagnosis is confirmed by a rheumatologist.
Select...
I am between 18 and 80 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently taking corticosteroids.
Select...
I do not have any health conditions that would make it unsafe for me to change my diet.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~varying times: (at baseline) 0, 4, 8, 12, 16, 20, 24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and varying times: (at baseline) 0, 4, 8, 12, 16, 20, 24 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Change in Disease Activity in Psoriatic Arthritis (DAPSA)
Change in Psoriasis Area and Severity Index (PASI)
Metabolic Profile- Blood Glucose Studies
+12 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Active Control
Group I: Diet 1Active Control1 Intervention
Diet 1 will focus on the dietary pattern and monitor types of foods, supplementary nutrition, and provide nutritional support with a dietitian.
Group II: Diet 2Active Control1 Intervention
Diet 2 will focus on the dietary pattern and monitor the amount of food, complimentary nutrition, and nutritional support with a dietitian.
Group III: Diet 3Active Control1 Intervention
Diet 3 will focus on healthy dietary patterns and provide nutritional support with a dietitian.

Find a Location

Who is running the clinical trial?

Women's College HospitalOTHER
106 Previous Clinical Trials
43,471 Total Patients Enrolled
2 Trials studying Psoriatic Arthritis
959 Patients Enrolled for Psoriatic Arthritis
University of PennsylvaniaLead Sponsor
2,078 Previous Clinical Trials
42,721,295 Total Patients Enrolled
9 Trials studying Psoriatic Arthritis
3,189 Patients Enrolled for Psoriatic Arthritis
NYU Langone HealthOTHER
1,409 Previous Clinical Trials
855,495 Total Patients Enrolled
4 Trials studying Psoriatic Arthritis
1,220 Patients Enrolled for Psoriatic Arthritis

Media Library

Diet 1 (N/A) Clinical Trial Eligibility Overview. Trial Name: NCT04180904 — N/A
Psoriatic Arthritis Research Study Groups: Diet 1, Diet 2, Diet 3
Psoriatic Arthritis Clinical Trial 2023: Diet 1 Highlights & Side Effects. Trial Name: NCT04180904 — N/A
Diet 1 (N/A) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04180904 — N/A
~19 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top